Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Austrian Breast & Colorectal Cancer Study...Active, not recruitingNeoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 MutationUnited States
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Taiwan, Italy, Turkey (Türkiye)
-
City University of New YorkMaimonides Medical CenterCompletedNutrition, Healthy | Lactation Disorder - Postpartum Condition or ComplicationUnited States
-
PfizerTerminatedNon-Small Cell Lung Cancer | Triple-negative Breast CancerUnited States
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompleted
-
International Maternal Pediatric Adolescent AIDS...University of Colorado, Denver; National Institute of Allergy and Infectious... and other collaboratorsRecruitingPregnancy Related | HIV-1-infection | BreastfeedingUnited States
-
NYU Langone HealthLynne Cohen Foundation for Ovarian Cancer ResearchCompletedBreast Cancer | Ovarian CancerUnited States
-
Biostar Pharma, Inc.RecruitingHER2-negative Breast Cancer Patients With Brain MetastasesUnited States
-
Novartis PharmaceuticalsNCIC Clinical Trials GroupCompletedBreast CancerUnited States, Belgium, Canada, United Kingdom, Argentina, Australia, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Taiwan, Thailand, India, Korea, Republic of, Mexico, Ukraine
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Puerto Rico
-
Stemline Therapeutics, Inc.RecruitingBreast CancerUnited States, Australia, Spain, Belgium, Canada, Malaysia, United Kingdom, Italy, Brazil, Germany, Netherlands, Hungary, Switzerland, Austria, France, Hong Kong, Taiwan, Romania, Singapore, Argentina, Portugal, Georgia, Czechia, Denmark and more
-
Aminex Therapeutics, Inc.RecruitingMelanoma (Skin Cancer) | HER2-low Hormone Receptor Positive Breast CancerUnited States
-
Sentara Norfolk General HospitalGeorge Mason University; Dorothy G. Hoefer FoundationCompleted
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Israel, Peru, Spain, Italy, Germany, Czechia, South Africa, Mexico, Taiwan, Australia, Brazil, Poland, Hungary, South Korea, Argentina
-
Eli Lilly and CompanyCompletedBreast Neoplasms | Neoplasm MetastasisIndia
-
Olema Pharmaceuticals, Inc.Novartis PharmaceuticalsRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Australia, Malaysia, Hungary, Romania, South Korea, Spain, United Kingdom, Hong Kong, Canada, Taiwan, Thailand, Greece, Italy, Poland, Austria, Belgium, Czechia, France, Germany, Netherlands, Portugal
-
Canadian Cancer Trials GroupNational Cancer Institute (NCI); ETOP IBCSG Partners Foundation; ICR-CTSUCompletedBreast CancerUnited States, Canada, Switzerland, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Novartis PharmaceuticalsTerminatedAdvanced Solid Tumors | Triple Negative Breast Cancer | Chordoma and Alveolar Soft Part SarcomaUnited States, Taiwan, Canada, Israel, Singapore, Italy, France, Spain, Japan
-
Hoffmann-La RocheCompletedBreast NeoplasmsUnited States, Israel, South Korea
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerUnited States, Switzerland, Spain, Germany, Brazil, Romania, Sweden, Canada, Israel, Taiwan, Austria, Belgium, Greece, Italy, Netherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NSABP Foundation IncCompletedBreast Cancer | Perioperative/Postoperative ComplicationsUnited States, Canada
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingBreast CancerUnited States, Spain, France, China, Belgium, Germany, Singapore, Japan, United Kingdom, Australia, South Korea, Canada
-
SanofiTerminatedBreast Cancer MetastaticBelgium, Taiwan, China, United States, Argentina, Australia, Canada, France, Italy, Latvia, Mexico, Spain, Ukraine, Greece, Israel, South Korea, Poland, Czechia, Brazil, Japan, Puerto Rico, Russia, Turkey (Türkiye)
-
Eli Lilly and CompanyWithdrawnMetastatic Breast CancerUnited States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupCompletedBreast CancerFrance, United States, Spain, Germany, Hungary, China, United Kingdom, Australia, Belgium, Denmark, Canada, Bulgaria, Croatia, Ireland, Mexico, Slovenia, Israel, Thailand, Japan, Czechia, Guatemala, Taiwan, Chile, Austria, Peru, Netherlands, Hong Kong and more
-
Infinity Pharmaceuticals, Inc.Active, not recruitingAdvanced Solid Tumors (Part A/B/C/D) | Non-small Cell Lung Cancer (Part E) | Melanoma (Part E) | Squamous Cell Cancer of the Head and Neck (Part E) | Triple Negative Breast Cancer (Part F) | Adrenocortical Carcinoma (Part G) | Mesothelioma (Part G) | High-circulating Myeloid-derived Suppressor Cells...United States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.TerminatedBreast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, France, Japan, United Kingdom, Canada
-
National Cancer Institute (NCI)NRG OncologyCompletedChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
NSABP Foundation IncNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
OnKure, Inc.RecruitingBreast Cancer | Advanced Solid Tumors | Advanced Cancer | PI3K Gene MutationUnited States, Spain, France, Italy, Belgium, South Korea
-
Bristol-Myers SquibbJanssen Biotech, Inc.CompletedAdvanced CancerUnited States, Switzerland, France, Puerto Rico, Italy, Germany, Australia, Canada, Spain
-
Oncorus, Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Cancer | Breast Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Advanced Solid Tumor | Liver Metastases | Colorectal Carcinoma | Non-melanoma Skin CancerUnited States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
PfizerActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, China, Canada, Taiwan, Japan, India, Argentina, Brazil, Australia, United Kingdom, Mexico, South Korea, Turkey (Türkiye), Israel
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
Novartis PharmaceuticalsRecruitingAdvanced HR+/HER2- Breast Cancer | Advanced CCNE1-amplified Solid TumorsUnited States, Australia, Canada, Denmark, France, Germany, Italy, Israel, China, Singapore, Spain, Taiwan, South Korea, Czechia, Japan, United Kingdom
-
AstraZenecaCompletedBreast Cancer | Ovarian CancerIndia
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerUnited States, France, Italy, Spain, United Kingdom, Canada, India, Thailand, Vietnam, Bulgaria, Belgium, Switzerland, Germany, Brazil, Japan, Poland, China, Malaysia, Taiwan, Austria, Hungary, Australia, Singapore, Hong Kong, South Korea, Turkey (Türkiye)
-
Bristol-Myers SquibbCompletedBreast CancerChina, Russian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBreast Cancer | FatigueUnited States
-
R-PharmCompletedCancer | Breast CancerTurkey, Chile, Belgium, Portugal, Spain, Italy, United States, Argentina, Austria, Brazil, Canada, France, Germany, Singapore, South Africa, Taiwan, United Kingdom, Israel, Australia, Korea, Republic of, Russian Federation, Ireland, Netherland... and more
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
BayerOnyx Therapeutics, Inc.CompletedBreast CancerSpain, Ireland, Japan, Russian Federation, United States, Australia, Austria, Czechia, Belgium, China, Germany, Hungary, Israel, South Africa, United Kingdom, France, Greece, Puerto Rico, Italy, Canada, Poland, Sweden, Argentina
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedAcute Pain | Breast Carcinoma | Peripheral NeuropathyUnited States
-
Seagen, a wholly owned subsidiary of PfizerActive, not recruitingHER2-positive Breast CancerUnited States, China, Canada, United Kingdom, Belgium, Spain, Switzerland, Australia, Singapore, Japan, France, Denmark, Netherlands, Sweden, Taiwan, Germany, Austria, Israel, Italy, South Korea
-
PfizerRecruitingBreast Cancer | Breast NeoplasmsUnited States, Germany, Italy, Japan, Canada, Spain, Australia, Puerto Rico, Brazil